Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Semaglutide is a GLP-1 receptor agonist while tirzepatide activates both GIP and GLP-1 receptors, which can lead to larger average weight loss in some trials
De Vivo DC, Bohan TP, Coulter DL, et al
FDA described it as approved 50 days after filing under the Commissioners National Priority Voucher pilot programan unusually fast NME approval
Nao-xue-shu oral liquid protects and improves secondary brain insults of hypertensive cerebral hemorrhage
US$ 21.03
US$ 27.11
US$ 26.19
US$ 21.84
US$ 22.27
US$ 23.93
US$ 28.42
US$ 20.92
US$ 25.50
US$ 24.99
US$ 27.25
US$ 25.60
US$ 20.06
US$ 29.00
US$ 22.81
